Wuxi AppTec Co (SHSE:603259) Interest Expense : ¥-231 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Wuxi AppTec Co's interest expense for the three months ended in Mar. 2025 was ¥ -66 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-231 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Wuxi AppTec Co's Operating Income for the three months ended in Mar. 2025 was ¥ 3,121 Mil. Wuxi AppTec Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -66 Mil. Wuxi AppTec Co's Interest Coverage for the quarter that ended in Mar. 2025 was 47.46. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Wuxi AppTec Co Interest Expense Historical Data

The historical data trend for Wuxi AppTec Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Interest Expense Chart

Wuxi AppTec Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-141.83

-68.11

-107.50

-53.60

-216.03

Wuxi AppTec Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-51.08	-55.97	-43.17	-65.81	-65.76

Wuxi AppTec Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-231 Mil.

Wuxi AppTec Co (SHSE:603259) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Wuxi AppTec Co's Interest Expense for the three months ended in Mar. 2025 was ¥-66 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥3,121 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥1,389 Mil.

Wuxi AppTec Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	3121.029	/	-65.761
	=	47.46

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Wuxi AppTec Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

WUXIF:USA WUXAY:USA 02359:Hong Kong WX8:Germany

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.

Executives

Chen Shu Hui	senior management
Yang	Director
Hu Zheng Guo	Director
	senior management
Yao Chi	Director
Chen Min	Director
Zhu Bi Xin	senior management
Yang	senior management
Chen Shu Hui	senior management
Hu Zheng Guo	Director

Wuxi AppTec Co Headlines

No Headlines